Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | Inquiry | $ 1,474.00 | |
25 mg | Inquiry | $ 3,145.00 | |
50 mg | Inquiry | $ 4,945.00 | |
100 mg | Inquiry | $ 7,517.00 |
Description | LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist. |
In vivo | LY2140023 (orally;?3, 10, and 300 mg/kg;?once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid and homovanillic acid (HVA)[1]. |
Synonyms | LY2140023 |
Molecular Weight | 366.41 |
Formula | C12H18N2O7S2 |
CAS No. | 635318-55-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pomaglumetad methionil anhydrous 635318-55-7 Neuroscience GluR LY 2140023 LY2140023 LY-2140023 inhibitor inhibit